Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation.

Fiche du document

Type de document
Périmètre
Langue
Identifiants
Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.cmi.2017.06.016

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/28652112

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1469-0691

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_3DD38C51841F5

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer



Sujets proches En

Aspergilloma

Citer ce document

F. López-Medrano et al., « Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation. », Serveur académique Lausannois, ID : 10.1016/j.cmi.2017.06.016


Métriques


Partage / Export

Résumé 0

To assess the risk factors for development of late-onset invasive pulmonary aspergillosis (IPA) after kidney transplantation (KT). We performed a multinational case-control study that retrospectively recruited 112 KT recipients diagnosed with IPA between 2000 and 2013. Controls were matched (1:1 ratio) by centre and date of transplantation. Immunosuppression-related events (IREs) included the occurrence of non-ventilator-associated pneumonia, tuberculosis, cytomegalovirus disease, and/or de novo malignancy. We identified 61 cases of late (>180 days after transplantation) IPA from 24 participating centres (accounting for 54.5% (61/112) of all cases included in the overall study). Most diagnoses (54.1% (33/61)) were established within the first 36 post-transplant months, although five cases occurred more than 10 years after transplantation. Overall mortality among cases was 47.5% (29/61). Compared with controls, cases were significantly older (p 0.010) and more likely to have pre-transplant chronic obstructive pulmonary disease (p 0.001) and a diagnosis of bloodstream infection (p 0.016) and IRE (p

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en